Asston Pharmaceuticals Share price

APL

Healthcare Small Cap

78

0.00 (0.00%)

Last updated on 23 Apr, 2026 | 15:31 IST

BUYSELL

Today's High

00

Today's Low

00

52 Week Low

65.20

52 Week High

126.00

Free Demat with Zero AMC*

Asston Pharmaceuticals Chart

ChartIQ

TradingView

Asston Pharmaceuticals Share Key Metrics

Volume

0.00 Market Cap

66.40 CR

LTQ@LTP

0@78.00

ATP

0 Var Margin

53.5 %

Circuit Range

62.4-93.6

Delivery %

100 %

Value

0.00 ASM/GSM

No

Market Lot

1000

Summary

Asston Pharmaceuticals share price stands at ₹78 at 23 Apr, 2026 | 15:31. The stock Asston Pharmaceuticals intraday movement has stayed between ₹00 and ₹00, while on a 52-week basis it has fluctuated from ₹65.20 to ₹126.00.

In terms of trading activity, Asston Pharmaceuticals has recorded a volume of 0 shares. The Asston Pharmaceuticals has a market cap of ₹8512360. The stock’s Average Traded Price (ATP) stands at ₹0, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 0, 7800.

The Asston Pharmaceuticals operates within a circuit range of ₹62.4-93.6 – ₹62.4-93.6, with a Value of ₹0.00. The Delivery Percentage for the day is 100%. Additionally, Asston Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1000.

Asston Pharmaceuticals Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

64.34

Sector P/B

3.51

Sec. Div. Yield

0.57

Asston Pharmaceuticals Resistance and Support

Pivot 78

Resistance

First Resistance

78

Second Resistance

78

Third Resistance

78

Support

First Support

78

Second Support

78

Third Support

78

Asston Pharmaceuticals Shareholding Pattern

2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

50.66%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.91%

Domestic Institutional Investors

0%

Retail

47.42%

Others

0.01%

Total Promoters

MAR '26

50.66%

Asston Pharmaceuticals Corporate Actions

Date	Agenda
2026-03-30	Notice of EGM & Others
2026-02-07	Raising of Funds
2026-01-05	Others
2025-11-14	Half Yearly Results
2025-10-16	Others
2025-08-25	A.G.M.

Asston Pharmaceuticals News

Asston Pharmaceuticals Ltd - 544445 - Notice Of Extraordinary General Meeting

Asston Pharmaceuticals announced an Extraordinary General Meeting (EGM) on April 28, 2026. The agenda includes the appointment of M/s Panchal SK & Associates as statutory auditors and the regularization of Mr. Yogesh Prakash Supekar, Mr. Yashvardhan Nitin Tupe, and Mr. Sandip Sharma as non-executive directors.

Apr 06 2026 18:04:00

Asston Pharmaceuticals Ltd - 544445 - The Extraordinary General Meeting Is Scheduled On Tuesday, 28Th April, 2026.

Asston Pharmaceuticals board appointed Mr. Sumit Pawar as CFO, Mr. Yashvardhan Tupe as Additional Non-Executive Director, and Mr. Sandip Sharma as Additional Non-Executive Independent Director. The board also approved an Extraordinary General Meeting (EGM) to be held on April 28, 2026.

Mar 30 2026 17:03:00

Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Meeting Updates

Asston Pharmaceuticals board appointed Mr. Sumit Pawar as CFO, Mr. Yashvardhan Tupe as Additional Non-Executive Director, and Mr. Sandip Sharma as Additional Non-Executive Independent Director. The board also approved an Extraordinary General Meeting (EGM) to be held on April 28, 2026.

Mar 30 2026 16:03:00

Asston Pharmaceuticals Ltd - 544445 - Board Meeting Outcome for Outcome Of The Board Meeting Schedule To Be Held On 30Th March, 2026

Asston Pharma appointed Mr. Sumit Pawar as CFO, Mr. Yashvardhan Tupe as Additional Non-Executive Director, and Mr. Sandip Sharma as Additional Non-Executive Independent Director, effective March 30, 2026. The board also approved an Extraordinary General Meeting for April 28, 2026, via video conference.

Mar 30 2026 16:03:00

Asston Pharmaceuticals Ltd - 544445 - Board Meeting Intimation for Scheduled To Be Held On 30Th March, 2026 At 3:00 P.M. At The Registered Office Of The Company

Asston Pharmaceuticals Board meeting on March 30, 2026, to consider appointment of Mr. Sumit Pawar as CFO, and Mr. Yashvardhan Tupe and Mr. Sandip Sharma as Additional Directors. The board will also approve the date and notice for an Extraordinary General Meeting.

Mar 25 2026 18:03:00

NSE : 0

BSE : 544445

ISIN : INE0SJX01015

Our Company was originally incorporated as “Asston Pharmaceuticals Private Limited” a private limited company under Companies Act 2013 pursuant to a certificate of incorporation dated April 16 2019 issued by Registrar of Companies Mumbai Maharashtra. Thereafter our Company was converted into a public limited company and the name of our Company was changed from “Asston Pharmaceuticals Private Limited” to “Asston Pharmaceuticals Limited” vide fresh certificate of incorporation dated August 29 2024 issued by the Registrar of Companies Mumbai Maharashtra. The Corporate Identification Number of our Company is U24304MH2019PLC324187.MAJOR EVENTS:2019- Incorporation of our Company viz. “Asston Pharmaceuticals Private Limited” under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.- Our Company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone Ghana and Liberia.2020- Our Company obtained registered trademarks in both India and abroad for multiple productsenhancing its images as a pharmaceutical brand in late 2020.2021- Our Company crossed the turnover of 10 cr turnover mark in 2021 less than two years since inception.2022- Established our Manufacturing unit in Mumbai which is one of our Company’s achievement making us an independent and reliable supplier.2023- Our Company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.2024- Conversion of our Company from Private Limited to Public Limited Company.

Name	Position
Ashish Narayan Sakalkar	Managing Director
Saili Jayaram More	Whole Time Director & Chief Executive Officer

Asston Pharmaceuticals Similar Stocks

Asston Pharmaceuticals FAQs

The Buying Price of Asston Pharmaceuticals share is 78 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Asston Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Asston Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Asston Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Asston Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Asston Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.34 & 3.51 with sector averages, along with growth rates and financial metrics.

The Market Cap of Asston Pharmaceuticals is 66.40 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Asston Pharmaceuticals share price is 126.00 & 65.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Asston Pharmaceuticals belongs to the Healthcare sector.